Replicel presentation january 12th

[Sogeking]

I think they will definitely start in first half of this year, however this Phase 2 is make it or break it for Replicel.

This is an excerpt from the pdf:

1. 160 participants
2. 396 RCH-01 treatment group sites (vs. 16 in P1), with 244 placebo sites
3. Designed to measure dosing and treatment frequency
4. Primary commercial endpoint –efficacy at 52 weeks after final injection
   efficacy measured as total density, hair thickness, cumulative hair and treatment response rate
   
5. Secondary endpoints –52 weeks
   local tolerance, systemic safety

Notice the bolded part: after 52 weeks (1 year) we will get the results for the Phase 2 data. That is when we will know how good RCH-01 really is. This is good. At least we won't be kept in the dark.
So expect results in H2 of 2016.

As for Shiseido I don't expect they will be forthcoming with news for the international scene. I think they will conduct their trials away from the public eye.